IBEX monthly performance report
Explore IBEX's monthly returns, drawdown, and seasonality trends — updated every month.
IBEX monthly report
—
Key takeaways
- IBEX (IBEX) closed November 2026 at $19,965.50, up 7.04% for the month and +20.16% over the trailing 12 months.
- Year-to-date, IBEX is +15.36%, outperforming the S&P 500 which has returned +11.03% YTD.
- The stock is trading +6.85% versus its 200-day moving average ($18,685.60), a bullish technical signal.
- Over the past three years, IBEX has outperformed the S&P 500 by +41.21%, with a relative strength index reading of 122.7.
- Win rate over the trailing 39 months stands at 64.1% — 25 positive months versus 14 negative months.
IBEX ended November 2026 at $19,965.50, posting a monthly return of +7.04%. The S&P 500 returned +0.19% over the same window, leaving relative performance at +6.85%.
The current quarter stands at +2.78% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +6.85% versus the 200-day moving average ($18,685.60).
Year-to-date, IBEX is +15.36% against SPY +11.03%, a gap of +4.33%. The stock is currently −1.92% below its 52-week high, with maximum 3-year drawdown at −12.60%.
| Period | IBEX | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.31% | −0.35% | +0.04% |
| 1 Week | +2.46% | +3.29% | −0.83% |
| 1 Month | +7.04% | +0.19% | +6.85% |
| 3 Months | −1.01% | −2.48% | +1.47% |
| 6 Months | +11.61% | +2.00% | +9.61% |
| YTD | +15.36% | +11.03% | +4.33% |
| 12 Months | +20.16% | +10.79% | +9.37% |
| 3 Years | +113.04% | +71.83% | +41.21% |
| Rank | Month | Return |
|---|---|---|
| #1 | Nov 2023 | +11.54% |
| #2 | Mar 2024 | +10.73% |
| #3 | Feb 2025 | +7.91% |
| #4 | Nov 2026 | +7.04% |
| #5 | Jan 2025 | +6.67% |
| Rank | Month | Return |
|---|---|---|
| #1 | Mar 2026 | −7.14% |
| #2 | Oct 2023 | −4.36% |
| #3 | Oct 2026 | −3.98% |
| #4 | Jun 2024 | −3.34% |
| #5 | Sep 2026 | −2.74% |
| Quarter | Return |
|---|---|
| Q3 2025 | +10.60% |
| Q4 2025 | +11.84% |
| Q1 2026 | −1.49% |
| Q2 2026 | +14.21% |
| Q3 2026 | −0.23% |
| Q4 2026 (QTD) | +2.78% |
| Year | Return |
|---|---|
| 2023 | +22.76% |
| 2024 | +14.78% |
| 2025 | +49.27% |
| 2026 | +15.36% |
| Metric | Value |
|---|---|
| 52-Week High | $20,356.50 (2026-08-13) |
| 52-Week Low | $15,724.60 (2025-11-21) |
| Current Price | $19,965.50 |
| 200-Day Moving Average | $18,685.60 |
| Price vs 200DMA | +6.85% |
| 3-Year Maximum Drawdown | −12.60% (2025-04-07) |
| Current Drawdown from 52W High | −1.92% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 122.7 |
| 3-Year Excess Return vs S&P 500 | +41.21% |
| RS Peak | 124.9 (Mar 2026) |
| RS Trough | 88.6 (Nov 2024) |
| Status | Outperforming Benchmark |
Frequently asked questions
What was IBEX's return for this report period?
IBEX returned +7.04% in the latest monthly window ending 2026-11-12.
Has IBEX outperformed SPY year to date?
YTD IBEX: +15.36% vs SPY: +11.03%.
What is IBEX's 12-month return?
+20.16% over the trailing 12 months.
Is IBEX above or below its 200-day moving average?
Price is +6.85% versus 200DMA ($18,685.60).
What is the maximum drawdown in the 3-year window?
−12.60% on 2025-04-07.